Star Scientific Announces Successful First Look at the "Flint" CRP Human Study and Provides Updated Report on ASAP Human Thyroid Study
Star Scientific, Inc. (NASDAQ: STSI), announced today that the Roskamp Institute has reported positive findings in its analysis of 100 subjects who completed the "Flint" CRP study that analyzes the effects of dietary supplementation with Anatabloc® in humans. The Company is also reporting additional information relating to its ASAP human thyroid study.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.